Report Detail

Request for Sample of this report

Pharma & Healthcare Global Peptide-based Injectable Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4544003
    • |
  • 25 July, 2023
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Peptide-based Injectable Drugs market size was valued at USD 33080 million in 2022 and is forecast to a readjusted size of USD 43880 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Injectable peptide drugs offer several advantages over other administration routes, such as oral or topical delivery. When injected, peptides can bypass the gastrointestinal tract, avoiding issues such as degradation by stomach acid or poor absorption. Additionally, injections can provide a more rapid and direct delivery of the drug into the bloodstream, allowing for faster onset of action.
Peptide-based injectable drugs refer to medications that contain peptides as their active ingredients and are administered via injection. Peptides are short chains of amino acids, which are the building blocks of proteins. They play crucial roles in various biological processes and can be used therapeutically to target specific cellular pathways or receptors.
This report is a detailed and comprehensive analysis for global Peptide-based Injectable Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Peptide-based Injectable Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Peptide-based Injectable Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Peptide-based Injectable Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Peptide-based Injectable Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peptide-based Injectable Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peptide-based Injectable Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Teva, Novo Nordisk, Takeda and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Peptide-based Injectable Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Brand
Generic Drug
Market segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
Market segment by players, this report covers
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
Roche
J & J
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Peptide-based Injectable Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Peptide-based Injectable Drugs, with revenue, gross margin and global market share of Peptide-based Injectable Drugs from 2018 to 2023.
Chapter 3, the Peptide-based Injectable Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Peptide-based Injectable Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide-based Injectable Drugs.
Chapter 13, to describe Peptide-based Injectable Drugs research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Peptide-based Injectable Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Peptide-based Injectable Drugs by Type
    • 1.3.1 Overview: Global Peptide-based Injectable Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Peptide-based Injectable Drugs Consumption Value Market Share by Type in 2022
    • 1.3.3 Brand
    • 1.3.4 Generic Drug
  • 1.4 Global Peptide-based Injectable Drugs Market by Application
    • 1.4.1 Overview: Global Peptide-based Injectable Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Cancer
    • 1.4.3 Metabolic Disorders
    • 1.4.4 Central Nervous System
    • 1.4.5 Other
  • 1.5 Global Peptide-based Injectable Drugs Market Size & Forecast
  • 1.6 Global Peptide-based Injectable Drugs Market Size and Forecast by Region
    • 1.6.1 Global Peptide-based Injectable Drugs Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Peptide-based Injectable Drugs Market Size by Region, (2018-2029)
    • 1.6.3 North America Peptide-based Injectable Drugs Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Peptide-based Injectable Drugs Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Peptide-based Injectable Drugs Market Size and Prospect (2018-2029)
    • 1.6.6 South America Peptide-based Injectable Drugs Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Peptide-based Injectable Drugs Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Peptide-based Injectable Drugs Product and Solutions
    • 2.1.4 Sanofi Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sanofi Recent Developments and Future Plans
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Peptide-based Injectable Drugs Product and Solutions
    • 2.2.4 Teva Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Teva Recent Developments and Future Plans
  • 2.3 Novo Nordisk
    • 2.3.1 Novo Nordisk Details
    • 2.3.2 Novo Nordisk Major Business
    • 2.3.3 Novo Nordisk Peptide-based Injectable Drugs Product and Solutions
    • 2.3.4 Novo Nordisk Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novo Nordisk Recent Developments and Future Plans
  • 2.4 Takeda
    • 2.4.1 Takeda Details
    • 2.4.2 Takeda Major Business
    • 2.4.3 Takeda Peptide-based Injectable Drugs Product and Solutions
    • 2.4.4 Takeda Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Takeda Recent Developments and Future Plans
  • 2.5 Eli Lilly
    • 2.5.1 Eli Lilly Details
    • 2.5.2 Eli Lilly Major Business
    • 2.5.3 Eli Lilly Peptide-based Injectable Drugs Product and Solutions
    • 2.5.4 Eli Lilly Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Eli Lilly Recent Developments and Future Plans
  • 2.6 AstraZeneca
    • 2.6.1 AstraZeneca Details
    • 2.6.2 AstraZeneca Major Business
    • 2.6.3 AstraZeneca Peptide-based Injectable Drugs Product and Solutions
    • 2.6.4 AstraZeneca Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 AstraZeneca Recent Developments and Future Plans
  • 2.7 Novartis
    • 2.7.1 Novartis Details
    • 2.7.2 Novartis Major Business
    • 2.7.3 Novartis Peptide-based Injectable Drugs Product and Solutions
    • 2.7.4 Novartis Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Novartis Recent Developments and Future Plans
  • 2.8 AbbVie
    • 2.8.1 AbbVie Details
    • 2.8.2 AbbVie Major Business
    • 2.8.3 AbbVie Peptide-based Injectable Drugs Product and Solutions
    • 2.8.4 AbbVie Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AbbVie Recent Developments and Future Plans
  • 2.9 Ipsen
    • 2.9.1 Ipsen Details
    • 2.9.2 Ipsen Major Business
    • 2.9.3 Ipsen Peptide-based Injectable Drugs Product and Solutions
    • 2.9.4 Ipsen Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Ipsen Recent Developments and Future Plans
  • 2.10 Ferring
    • 2.10.1 Ferring Details
    • 2.10.2 Ferring Major Business
    • 2.10.3 Ferring Peptide-based Injectable Drugs Product and Solutions
    • 2.10.4 Ferring Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Ferring Recent Developments and Future Plans
  • 2.11 Merck
    • 2.11.1 Merck Details
    • 2.11.2 Merck Major Business
    • 2.11.3 Merck Peptide-based Injectable Drugs Product and Solutions
    • 2.11.4 Merck Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Merck Recent Developments and Future Plans
  • 2.12 The Medicines
    • 2.12.1 The Medicines Details
    • 2.12.2 The Medicines Major Business
    • 2.12.3 The Medicines Peptide-based Injectable Drugs Product and Solutions
    • 2.12.4 The Medicines Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 The Medicines Recent Developments and Future Plans
  • 2.13 Roche
    • 2.13.1 Roche Details
    • 2.13.2 Roche Major Business
    • 2.13.3 Roche Peptide-based Injectable Drugs Product and Solutions
    • 2.13.4 Roche Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Roche Recent Developments and Future Plans
  • 2.14 J & J
    • 2.14.1 J & J Details
    • 2.14.2 J & J Major Business
    • 2.14.3 J & J Peptide-based Injectable Drugs Product and Solutions
    • 2.14.4 J & J Peptide-based Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 J & J Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Peptide-based Injectable Drugs Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Peptide-based Injectable Drugs by Company Revenue
    • 3.2.2 Top 3 Peptide-based Injectable Drugs Players Market Share in 2022
    • 3.2.3 Top 6 Peptide-based Injectable Drugs Players Market Share in 2022
  • 3.3 Peptide-based Injectable Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Peptide-based Injectable Drugs Market: Region Footprint
    • 3.3.2 Peptide-based Injectable Drugs Market: Company Product Type Footprint
    • 3.3.3 Peptide-based Injectable Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Peptide-based Injectable Drugs Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Peptide-based Injectable Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Peptide-based Injectable Drugs Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Peptide-based Injectable Drugs Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Peptide-based Injectable Drugs Consumption Value by Type (2018-2029)
  • 6.2 North America Peptide-based Injectable Drugs Consumption Value by Application (2018-2029)
  • 6.3 North America Peptide-based Injectable Drugs Market Size by Country
    • 6.3.1 North America Peptide-based Injectable Drugs Consumption Value by Country (2018-2029)
    • 6.3.2 United States Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Peptide-based Injectable Drugs Consumption Value by Type (2018-2029)
  • 7.2 Europe Peptide-based Injectable Drugs Consumption Value by Application (2018-2029)
  • 7.3 Europe Peptide-based Injectable Drugs Market Size by Country
    • 7.3.1 Europe Peptide-based Injectable Drugs Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 7.3.3 France Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Peptide-based Injectable Drugs Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Peptide-based Injectable Drugs Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Peptide-based Injectable Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Peptide-based Injectable Drugs Consumption Value by Region (2018-2029)
    • 8.3.2 China Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 8.3.5 India Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Peptide-based Injectable Drugs Consumption Value by Type (2018-2029)
  • 9.2 South America Peptide-based Injectable Drugs Consumption Value by Application (2018-2029)
  • 9.3 South America Peptide-based Injectable Drugs Market Size by Country
    • 9.3.1 South America Peptide-based Injectable Drugs Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Peptide-based Injectable Drugs Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Peptide-based Injectable Drugs Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Peptide-based Injectable Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Peptide-based Injectable Drugs Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Peptide-based Injectable Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Peptide-based Injectable Drugs Market Drivers
  • 11.2 Peptide-based Injectable Drugs Market Restraints
  • 11.3 Peptide-based Injectable Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Peptide-based Injectable Drugs Industry Chain
  • 12.2 Peptide-based Injectable Drugs Upstream Analysis
  • 12.3 Peptide-based Injectable Drugs Midstream Analysis
  • 12.4 Peptide-based Injectable Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Peptide-based Injectable Drugs. Industry analysis & Market Report on Peptide-based Injectable Drugs is a syndicated market report, published as Global Peptide-based Injectable Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Peptide-based Injectable Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,225.96
    		4,838.94
    		6,451.92
    		542,984.40
    		814,476.60
    		1,085,968.80
    		290,649.60
    		435,974.40
    		581,299.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo